Fundraising Fox

Nuvalent

Cambridge, US · Founded 2017 · Delaware corporation · 2 known investors

Founders & leadership

Nuvalent was founded in 2017 by Matthew Shair.

MSMatthew Shair
Matthew ShairFounder
RP
R. Porter JamesExecutive
ABAlex Balcom
Alex BalcomExecutive

Board

AHAndrew Hack
Andrew HackBoard directorPartner at Bain Capital Life Sciences
CW
Cameron WheelerBoard director
JP
Joseph PearlbergBoard director
GG
Gary GillilandBoard director
RJ
Robert JacksonBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$135M disclosed across 1 round · 2021

$135MraisedMay 2021 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew ShairDirector
  • Andrew HackDirector
  • Cameron WheelerDirector
  • Gary GillilandDirector
  • Robert JacksonDirector
  • Joseph PearlbergDirector
  • R. Porter JamesExecutive Officer, Director
  • Alex BalcomExecutive Officer
Offering amount
$135M
Amount sold
$135M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Nuvalent for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

Who founded Nuvalent?
Nuvalent was founded by Matthew Shair in 2017.
Who are Nuvalent's investors?
Nuvalent's investors include Avoro Capital Advisors, Bain Capital Life Sciences.
How much funding has Nuvalent raised?
Nuvalent has disclosed $135M raised across 1 round.
Where is Nuvalent headquartered?
Nuvalent is headquartered in Cambridge, US.